PATHFAST™ B·R·A·H·M·S PCT™ is an immunoassay for the in vitro quantitative determination of procalcitonin (PCT) concentration in whole blood, plasma or serum on the PATHFAST system from LSI Medience Corporation. The PATHFAST B·R·A·H·M·S PCT assay principle is based on chemiluminescence enzyme immunoassay (CLEIA) and MAGTRATION®* methodology.
PATHFAST B·R·A·H·M·S PCT is CE marked.
PATHFAST B·R·A·H·M·S PCT assay can be distinguished by these characteristics:
Limit of quantitation (LoQ) and limit of detection (LoD) values are rounded to 3 decimal places in alignment with the reported results for the assay.
Correlation between PATHFAST B·R·A·H·M·S PCT and Thermo Scientific™ B·R·A·H·M·S PCT™ sensitive KRYPTOR™.
Four plasma samples were assayed in duplicate for 20 non-consecutive days. The within-run and total standards deviations (SD) and coefficient of variations (CV) were calculated according to the CLSI document EP5-A2.
*MAGTRATION is a technology of B/F separation where magnetic particles are washed in the pipette tip.
Thermo Fisher Scientific products are distributed worldwide; not all intended uses and applications are registered in every country. Availability of product in each country depends on local regulatory marketing authorization status.